Fetuses of diabetic mothers who were exposed to excessive glucose show dela
yed maturation. Under these conditions, altered growth factor expression or
signaling may have important regulatory influences. We examined the role o
f epidermal growth factor (EGF) in lung development and maternal diabetes i
n the rat. In order to evaluate the possible role of glucose for the expres
sion of EGF and the growth of lung tissue, we performed in vitro studies wi
th organotypic cultures of fetal alveolar cells obtained from control rats.
Compared to pups of normal rats, the newborn rats of untreated diabetic rat
s had reduced body weight, but normal lung weight relative to body weight.
The air:mesenchyme ratio and the average size of alveoli per mm(2) lung tis
sue were reduced. The immunoreactivity (IR) of EGF, which was quantified us
ing a computerized image analysis system, appeared with increased intensity
and was associated with a reduced intensity of surfactant protein A-IR. Th
e only difference observed between pups of treated diabetic rats and contro
ls was a decrease in the lung weight:body weight ratio. In organotypic cult
ures, the presence of 13 mmol/L glucose in the cell media increased immunor
eactive staining against EGF, but decreased the incorporation of thymidine
as compared to the results obtained with alveolar cells grown in a normophy
siological concentration of glucose (3 mmol/L). Addition of EGF increased t
he thymidine incorporation only in cells grown in 3 mM glucose.
These findings may indicate immaturity of the lungs of pups of untreated di
abetic rats, and subtle alterations in the lungs of pups from treated diabe
tic rats. The results also suggest that glucose plays a role in the express
ion of EGF, and that cells exposed to high concentrations of glucose are le
ss responsive to EGF. Pediatr Pulmonol. 2000; 29:103-112. (C) 2000 Wiley-Li
ss, Inc.